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ABSTRACT
BIPHASIC GENE ELECTROTRANSFER ENHANCES GENE DELIVERY IN VITRO
John Bui
Old Dominion University, 2020
Director: Dr. Anna Bulysheva
The application of short, pulsed electric fields to eukaryotic cells and tissues has been
shown to permeabilize cells. This phenomenon has been used for clinical applications for
irreversible electroporation of cancer cells or for molecule delivery for drug or gene therapies.
Typically, a monophasic (monopolar) pulse train is used; however, recent studies have explored
the possibility of using biphasic (often referred to as bipolar) pulses, primarily for irreversible
electroporation (IRE), which report reduced muscle contraction during pulse train application
compared to monophasic pulses. Additional studies show improved transfection efficiency using
biphasic pulses, conversely, with low cell viability. The purpose of this current study is to
evaluate parameters of biphasic pulses for improving gene transfer in vitro. B16-F10, mouse
melanoma cells were cultured, suspended, and treated with microsecond pulsed electric fields in
a 1mm cuvette. Various pulsing parameters were used to deliver either propidium iodide (PI) or
plasmid DNA encoding green fluorescent protein (GFP) to observe cell permeabilization and
transfection. Cell viability was evaluated via PrestoBlue assay. Increasing pulse trains to 8 and
increasing positive pulse width to 100 us at low voltage of 40 V, both resulted in significant
changes in transfection efficiency with reduced viability. On the other hand, increasing voltage
to 120 V shows significantly enhanced transfection efficiency with low viability. Lastly,
reducing positive pulse width to 20 us at 120 V applied, resulted in high transfection efficiency
at 43% with high cell viability at 84%. This study shows that biphasic pulses enhance gene

delivery of plasmid encoding GFP into B16-F10 and maintain high cell viability in vitro.
These results are consistent with earlier studies that gene delivery enhancement is feasible with
biphasic pulses. Additional, future studies will evaluate whether such gene delivery enhancement
can be maintained in excitable cells without actional potential activation.
Keywords: biphasic pulses, monophasic pulses, gene electrotransfer, transfection efficiency,
cell viability.
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NOMENCLATURE

BPC

Bipolar Pulse Cancellation

DOTMA

1,2-di-O-octadecenyl-3-trimethylammonium propane

ECG

Electrocardiogram

ECT

Electrochemotherapy

FBS

Fetal Bovine Serum

GET

Gene Electrotransfer

GFP

Green Fluorescent Protein

DMEM

Dulbecco’s Modified Eagle Medium

IHC

Immunohistochemistry

IRE

Irreversible Electroporation

PBS

Phosphate-Buffered Saline

PAMAM

Polyaminoamine

PEI

Polyethyleneimines

PPI

Polypropyleneimine

PI

Propidium Iodide

VEGF

Vascular Endothelial Growth Factor
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CHAPTER I
INTRODUCTION

The use of short pulsed electric fields on eukaryotic cells has been shown to increase cell
permeabilization. This phenomenon has numerous clinical applications such as tissue ablation or
delivery of drugs and genes into the permeabilized cells. These applications often use
monophasic (monopolar) pulses, but recent research has explored the possibility for biphasic
(often referred to as bipolar) pulses, mainly for tumor ablation. The term monopolar and
monophasic have been used interchangeably in research to describe waveforms of a single
polarity. Bipolar and biphasic has been used interchangeably in numerous studies to describe
waveform that uses both polarities. In a study by Chiapperino et al, the term monopolar and
bipolar has been used to explain the pulse wave for their experiment [1]. In a study by Tovar and
Tung, the term monophasic and biphasic has been used to explain the rectangular waves used for
their experiments [2]. In a study by Long et al, they defined monopolar as a type of probe
(electrode) they used and monophasic as the waveform for their tumor ablation protocol [3]. For
this study, monophasic is defined as the waveform of a pulse wave that only uses one polarity.
Biphasic will be defined as the waveform that uses both polarities alternating in cycles.
Monopolar will be defined as the probe that induces a voltage from an applicator to a grounding
pad. Lastly bipolar will be defined as the probe that has two electrodes which can function a
cathode. Few studies have emerged that utilize biphasic pulses for gene electrotransfer or
delivery of gene using electrical pulse. Among those studies the parameters often yielded low
transfection with high cell survivability or vice versa. The purpose of this study is to determine
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more efficient biphasic pulse parameters for transfection of plasmid DNA into B16-F10 murine
melanoma cells while maintaining high cell viability.
Gene Therapy
Gene therapy is a technique of introducing a foreign genomic material into the cell to
produce a therapeutic result [4]. This field encompasses replacing defective genes, restoring
specific gene functions, or turning off or deleting defective genes [4][5]. While there is strong
understanding of genetic mutations that lead to innumerable amount of diseases, target delivery
to disease organs and tissue postured many difficulties [6]. Gene therapy is divided into two
categories: germline which is delivery to cells during their metaphase stage, ex-vivo delivery to
egg cells during in-vitro fertilization, or delivery to sperm cells [4][5]. Somatic therapy is
delivery of gene into diploid cells of individual where genetic properties will not be passed onto
offspring. Modern gene delivery preferred somatic gene delivery over germline gene delivery
[4][5]. The ideal delivery system [5] is best characterized as:
•

Able to include a wide array of inserted DNA

•

Easy to produce and cost effective

•

Able to target specific type of cells

•

Does not duplicate DNA

•

Will not initiate an immune response

•

Maintain high cell viability
Viral methods consist of utilizing viral vectors such as adenovirus, retrovirus, poxvirus,

adeno-associated virus and herpes simplex virus [6]. These viruses are manipulated by removal
of the viral genes that cause disease and replaces them with therapeutic genes. Genes in the viral
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vector that are kept are genes that express sequences for DNA replication and packaging [7].
The host immune system is still capable of recognizing it as a threat and initiating an immune
response against the vector [4][5][6]. The viral vectors still hold some of the traits of a virus.
Portion of the vector may contain proteins that bare resemblance to antigens. Once the vector
has been administered into the body, it can be recognized by the host’s adaptive immune system
if the hosts has been previously exposed that particular virus. It can also trigger the host’s innate
immune system based on viral structures such as nucleic acid and cause production of INFα,
which will reduce transduction and create a signal for the adaptive immune system, making
subsequence application less effective [8].
Non-viral methods are gene delivery using chemical or physical means. Chemical
method includes using cationic liposome and polymers and physical includes electroporation,
ultrasound, magnetofection, or particle bombardment [4]. The chemical delivery system uses
interaction between cationic particles, polymers, or lipid polymers, and cell surface [9]. A
liposome is a positively charged lipid called 1,2-di-O-octadecenyl-3-trimethylammonium
propane (DOTMA), that alone or with another phospholipids (from cell membrane), will form a
liposome vesicle. Since DNA is negatively charged and DOTMA is positively charged, the
proper ratio between the two will facilitate movement of the vesicles. With the lipid membrane
being negatively charged, the positively charged DOTMA will interact with the cell membrane
where it will fuse [10]. Once inside the cytoplasm of the cells, through various microtubules and
motor proteins guide the vesicle to the nucleus [10]. The downside is that the delivery can be
toxic and has been shown to cause low viability [9]. Additionally, polymers can be used to
deliver DNA into cells. Cationic polymer uses dendrimers such as polyaminoamine (PAMAM),
polyethyleneimines (PEI), and polypropyleneimine (PPI) [11]. These dendrimers have the gene
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material within the branches. The polymer is delivered into the cells through endocytosis and
with the positive charge of the cationic polymers and the negative charge of the DNA, it will
make its path to the nucleus where the dendrimers release their materials through means such as
proton sponge in which the low pH in the endolysosomal complex that results in rupture of the
endolysosomal membrane that releases the gene. The advantage with cationic polymer is that it
can condense DNA plasmid, with the downside involving its cytotoxicity especially with the
polymers being non-biodegradable [11].
Gene gun is a form of particle bombardment that uses gold or tungsten spherical particles
coated with plasmid DNA accelerated by pressurized gas or electrical shockwave into the tissue
cell [12]. Magnetofections use a magnetic field to concentrate particles containing nucleic acid
into the cell [13]. In magnetofections, nanoparticles are used that are coated with cationic
polymers typically used in chemical method of delivery. A magnetic field is applied in the area
which causes the particles to concentrate at the site where the cationic polymer will assist in
delivery to the nucleus [13]. The downside with magnetofections is that it still uses cationic
polymer which are toxic to cells and will affect viability [11]. Electroporation uses repetitive
high voltage, short electrical pulses to form temporary pores in cells that allows for delivery of
DNA plasmids [14].
Application of gene therapy can be used to replace a defective gene, to delete a gene, or
to add a missing gene. Genetic disease such as diabetes was studied in rats, where a gene was
inserted into the liver to manage blood glucose level and ketogenesis. The result was there was
ketoacidosis was mitigated and normoglycemia was observed [5]. Non-genetic condition such as
cancer has numerous studies for gene therapy. One study delivered cytokines such as IL-12, IL2, and IL-15 into cancer cells. An immune response was initiated, resulting in tumor size
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reduction at the site of the transfection and even at metastatic location in some patients [15].
Gene therapy can be applied into regenerative medicine in which genes that causes upregulation
of growth factors can be used to restore cells or proteins. In a study, naked plasmid encoded
with vascular endothelial growth factor (VEGF) gene was injected into the myocardium. The
results show that the gene promoted neovascularization of the ischemic region of the heart,
which lead to an increase in the patients’ perfusion score [16]. Gene therapy has many different
methods of delivery, each with benefits and risk.
Electroporation
Electroporation is characterized as the phenomenon of inducing a high voltage, short
electrical pulses to eukaryotic cells. This process will result in the cell being permeabilized,
allowing for the introduction of molecules that cannot normally enter the cells [17][18]. The
concept of the mechanism behind this phenomenon has been a subject for discussion since its
discovery. Experts believed that the permeabilization of the membrane is due to disruption of
the boundary between the lipid composition, deformation of the lipid membrane, or denaturation
of the membrane proteins, but the consensus is that pores form through the lipid bilayer of the
cell [15]. This permeabilization is either reversible where the membrane can be resealed with
minimal damages to the cells or irreversible where the membrane cannot recover resulting in
apoptosis or cell death [14].
Electrical pulses used to permeabilize cells are typically square-pulse waves. Squarepulse waves can best be defined as having very rapid charging time to a constant amplitude
followed by a very rapid decay time for one cycle [19]. When using these electrical pulses, a lot
of variables are taken into consideration that can determine the effect of the cell
permeabilization. Field strength or voltage amplitude is often measured in voltage (V), it
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determines the maximum electrical field the cells are exposed to. High voltage often leads to
more irreversible results. Pulse width is the amount of time the cells are exposed to an individual
pulse at the determined voltage. Pulse width can range from ps to ms. Longer pulse width
means longer exposure time to the voltage for the cells, which can lead to more cell death. Pulse
number is the amount of pulses applied in an experiment. A higher pulse number means more
repeated exposure to the pulse, which can cause more pore formation. Period is the time in
between each cycle of pulse. Longer periods often lead to higher cell viability [16].
Pore formation typically happens within microseconds of electrical pulse exposure and
will continually form more pores or stay open until the pulse ceases. If the parameter is not as
intense, resealing can occur, but it is normally a much slower process that can take up to minutes
[20]. Resealing of the cellular membranes comes with its merits with the delivery of drugs or
delivery of genes [21][22]. Electrochemotherapy (ECT) is a treatment that takes advantage of
the rise in permeabilization of the membrane to introduce drugs into the cells that were
considered too difficult to introduce in the cell [17]. Anti-cancer drugs such as bleomycin have
been used with cells exposed to a train of high energy microsecond pulses in an experiment
results in regression of tumor size when both electrical pulses and bleomycin were used in
tandem [17]. Bleomycin cause multiple DNA break in the tumor and cisplatin causes intra or
inter-strand DNA bond; making them a preferred drug for delivery in cancer cells [18].
Bleomycin and cisplatin are typically too large to cross the cell membrane through endocytosis
or ion channels. By raising the permeability of the cell membrane through pulse electric fields,
pore formation will be large enough to facilitate the transport of those drugs into the cells that are
exposed to the field and not surrounding cells thus making the treatment safer than conventional
chemotherapy [18].
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Gene electrotransfer (GET) is a physical non-viral form of gene delivery, in which a train
of high energy electrical pulses will permeabilize the cells to allow for the introduction of DNA
plasmid [20]. Using the proper parameters, DNA plasmid can pass through both the lipid
membrane and the cytoplasm into the cell nucleus where gene expression occurs [21][22].
Transfection efficiency is dependent on the histology and phenotype of the cells. Typically,
skeletal muscles are easier to transfect due to being polynucleate and easy to access, while tumor
cells are much more difficult to transfect [23]. Gene electrotransfer is similar to
electrochemotherapy in concept. A set of high energy short pulses is exposed to the cells to
which they will permeabilize, and plasmids that are encoding genes will pass through the lipid
bilayer and the nuclear envelope to which the gene will bind to the DNA and express [16].
Applications of GET were mainly conducted with transfection of immunostimulatory cytokines
such as IL-12, IL-2, IL-15, and TNF-α into the cancer to initiate an immune response [16]. The
result shows that with IL-12 transfected into metastatic tumor cells, tumor size regression
occurred with two patients even having complete regression of metastasized tumor without any
systemic treatment [24].
Delivery of high power, short electrical pulses above a certain threshold can cause pores
to be permanent, leading to cells apoptosis [25][26]. Tumor ablation through pulse electric field
uses the principle of permeabilization to cause permanent pore formation, in which homeostasis
in the cell cannot be maintained; this will lead to osmotic effect of the cell internal [27]. With
the cell death, cell debris is left behind for the patient’s innate immune system to recognize [28].
The medical application is ablation of tumors with the advantages of having a nonthermal effect
resulting in sparing of blood vessel, inducing an immune response, and killing tumor cells [29].
Modern method of ablation typically relied on thermal principles in order to kill tumors.
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Hyperthermal ablation utilizes probes and electrodes that use radiofrequency waves with
frequency of 375-500 kHz to generate heat to raise the temperature of the cells. Between 42℃
to 45℃, vital enzymes for tissue function are disabled, leading to tissue damage [30]. Low
temperature can also be used to ablate tumors through similar applications but different
mechanisms [29]. Cryoablation is another form of thermal ablation that uses temperatures as
low as -40℃ to induce cell death. The process uses argon gas or liquid nitrogen through the
applicator to remove heat from the tissue resulting in crystal formation that will dehydrate the
cell, causing the cells to shrink while the ice crystal continually forms resulting in cell damage
[31]. Like hyperthermal ablation, cryoablation can also induced significant damages by
removing heat from surround tissues. Irreversible electroporation is preferred as the cell damage
is more intended and collateral damage is minimized due to absence of thermal effect [29].
Monophasic and Biphasic Electropermeabilization
Many studies in the field of pulse electric field involves the use of monophasic pulses.
Monophasic is often referred as monopolar, but for this study, the term monophasic will be used
to describe the wave form of the pulse that utilize only one polarity [32], and monopolar will be
used to describe the electrode. There is a wide array of research that utilizes monophasic pulses
such as tumor ablation, gene electro transfer, electrochemotherapy, and electrical stimulation of
nerve [16]. The major issue with the using monophasic pulses includes sensation of pain and
muscle contractions [33]. Muscle contraction has been proved to be problematic in-vivo as extra
precaution is taken prior to administering the treatment. Muscle contraction can cause organ
translocation if not properly managed, thus requiring neuromuscular blockade [34]. Before
inducing any electrical pulse, the patient may need to be anesthetized or administered a paralytic
agent. With regard to the patient, strict monitoring is also required and synchronization with the
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cardiac cycle has to be adhered to [35]. Muscle contraction can further complicate the procedure
as it is able to dislocate the position of the electrical probe used for the treatment especially when
used in sensitive areas [36]. Tumor ablation near the heart with monophasic pulse has shown to
induce ventricular arrythmia. During irreversible electroporation, the electric field from the
applicator are set to high voltage. The magnitude of the field will dissipate throughout
surrounding tissue thus potentially creating an area of reversible electroporation. The
myocardium receiving electrical stimulation from this field can prematurely initiate an action
potential, leading to ventricular arrythmia. ECG monitoring and synchronizing are practiced
when performing tumor ablation near the heart to minimize the risk of ventricular arrythmia [37].
Biphasic pulses are often called bipolar pulses and the term has been used
interchangeably in various literature. For this study, bipolar pulses are referring to the probe
used, while biphasic pulses are defined as a waveform that utilize both positive and negative
polarity wave to perform the treatments [38]. Biphasic pulses are typically shorter in pulse
length for both polarity and uses higher frequency to achieved similar permeabilization [33].
Higher amplitude is required for biphasic pulses in order to receive the same permeabilization as
long monophasic pulses [26]. For pulses to achieve membrane permeabilization, pulse
amplitude is inversely proportional to pulse width [33]. This is to be taken in consideration as
the longer the pulse width the more energy is deposited into the cell. Thus, for permeabilization
to occur with regard to cell viability, higher amplitude requires shorter pulse and longer
amplitude requires less energy.
Inter-pulse delay is the time in between the positive and negative pulse phase. The
timing of the delay is especially important to consider. In biphasic pulses, the delay does not
have an effect on the transmembrane potential, but it does have a substantial effect on the nuclear
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envelope potential. With a short delay, the falling voltage from the positive voltage is added to
the nuclear envelope as negative is rising. With delay as low as 140 ns, the nuclear envelope
potential can be double. A long delay will give the positive voltage time to reach zero before the
negative voltage builds up, thus reducing the nuclear envelope potential [33].
The advantage of biphasic is the reduced necessity of the pulse electric field on the pore
size as compared to monophasic pulses allowing for cells to be permeabilize. With nanosecond
pulse, biphasic can penetrate heterogenous tissues, allowing for more foreseeable treatment
results [39]. The impedance changes in high frequency biphasic pulses is significantly
minimized, which affect the distribution of the local field [40]. This reduction in impedance can
reduce muscle contraction, which obviates the complications caused from the contractions [26].
Much research that uses biphasic pulses often employs them for tumor ablation. This research
shows that muscle contraction does not occur, and tumor size is reduced after treatment [35][36].
Some research in the field of biphasic pulses explores use of these pulses for
electrochemotherapy. The technique is similar to modern method of electrochemotherapy, but
high-frequency biphasic pulses are used to permeabilize the cells [40].
Biphasic pulses require higher voltage amplitude than long monopolar pulses to achieve
the same efficacy. This is due to the effect known as bipolar pulse cancellation (BPC). Bipolar
pulse cancellation is a phenomenon in which permeabilization of cells is compromise due to the
second pulse of opposite polarity tailing the first. The first pulse initiating the process of
permeabilization, allowing for occluding molecule to leave, which affects the concentration
gradient in the cells [25]. The second opposite pulse can reinsert those occluding molecules back
into the pore raising the concentration gradient, affecting permeabilization for other molecules
[41]. This leads to requiring higher pulse amplitude to achieve permeabilization similar to
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monophasic. Since higher amplitude increases permeabilizes of the cells, bipolar pulse
cancellation will therefore reduce that permeabilization down to match monophasic
permeabilization [41]. Bipolar pulse cancellation can be mitigated by raising the polarity delay,
which treats both waves as independent waves instead of sequential waves [41].
Electrochemotherapy can employ the use of biphasic pulse wave to introduce drugs such as
cisplatin into cells. The procedure is similar to monophasic, but high-frequency biphasic pulses
are used instead. Results show that higher amplitude is required for the same cytotoxicity and
shows feasibility in a reversible effect [42]. Gene electrotransfer is able to utilize biphasic pulses
to deliver DNA plasmid into cell. The treatment is the same as monophasic, in which the
plasmid is deliver to the site and the pulse is induced. The results show biphasic pulses can
transfect plasmids into cells [20][22][43].
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Figure 1: Graph presenting the waveform of biphasic and monophasic pulses (A) Monophasic
pulse waveform (120 V amplitude, 100 us pulse width, 1 second period). (B) Biphasic pulse
waveform (+120 V/-120 V amplitude, +20 us/-20 us pulse width, 5 us polarity delay, 100 us
period).
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Project Aim
The purpose of this project is to investigate the use of biphasic pulses for gene
electrotransfer. Many different forms of gene transfer have shown success in literature. Viral
based vectors have high transfection efficacy but have been shown to initiate an immune
response and caused patient morbidity [8]. Chemical forms of delivery have been used in which
cationic liposome and polymers were used to deliver plasmid into the cell. The results yielded
good transfection efficiency, but low cell viability to the cytotoxic nature of the polymer and
compound [10][11]. Many physical methods of transfection have low transfection efficiency.
Gene electrotransfer has shown to have high transfection efficiency and high viability [14].
In a previous study, biphasic pulses were used to transfect plasmid DNA into NIH 3T3
fibroblast cells. The results show that biphasic pulses transfect 1.7x better than monophasic, but
cell viability was exceptionally low at 44%-62% due to the condition being too extreme with
high voltage, long pulse width, and low delay [22]. To this day, gene electro transfer with
biphasic pulses has not resulted in both high transfection efficiency of plasmid and high cell
viability. The aim for this project is to determine if high transfection efficiency and high cell
viability can be achieved using biphasic pulses in comparison to monophasic pulses. The
consideration taken is to keep the delay high enough to allow for the cells to recover, but low
enough to minimize muscle contractions.
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CHAPTER II
METHODS AND MATERIALS
Cell Culture
B16-F10 Cells (ATCC, Manassas, Virginia) were cultured in a 75 cm3 flask in 15 ml
McCoy Media (supplemented with L-glutamine, Corning, Manassas, Virginia) containing 10%
fetal bovine serum (FBS)(R&D Systems, Flowery Branch, Georgia) and 1% of final
concentration of gentamicin (R&D Systems, Flowery Branch, Georgia) at 37 °C in 5% CO2 in an
incubator. All cells were harvested for experiments by trypsinization at 80% confluency using 3
mL of 0.25% EDTA (R&D Systems, Flowery Branch, Georgia) for 5 minutes. Trypsinization
was blocked by adding 7 mL of media containing 10% FBS and 1% gentamicin. Suspended
cells were centrifuged for 5 minutes. Cells were counted using the Cellometer (Nexcelom
Bioscience, Lawrence, Massachusetts). Trypsin-media solution was removed and cells were
resuspended with new media. Cells were placed into individual 0.1 cm gap sterile cuvettes
(Biosmith, Vandergrift, Pennsylvania) at a density of 6x105 cell/100µl.
Electrotransfer Protocol
Gwiz-GFP plasmid DNA (2mg/ml, Aldevron, Fargo, North Dakota) are stored in a freeze
at -20℃, thawed to room temperature, and mixed at a volume of 1.25 uL with 100 uL of media
containing 6x105 cells in each cuvette for group pulsed with GFP. Concentration of 200ug for
every 100 uL of plasmid DNA was used.
Propidium iodide (PI, Millipore Sigma, St. Louis, Missouri) were warmed up and mixed
at a volume of 5 uL containing 100 uL of media containing 6x105 cells in each cuvette for group
pulsed with PI. Electrotransfer experiments were conducted using cuvettes (Biosmith,
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Vandergrift, Pennsylvania) with a .1 cm gap in between the electrodes, with volumes of 100 uL.
Stock concentration is 1mg/mL.
The generator used is an Electrocell B-10 pulse generator (Leroy, Saint-Orens-de-Gameville,
France), which is capable of generating monophasic and biphasic pulses. The parameters
available are positive voltage, negative voltage, period, pulse number, positive pulse length,
negative pulse length, and polarity delay shown in Fig. 1. The positive voltage sets the maximum
positive amplitude of the square-wave. The negative voltage sets the maximum negative
amplitude of the square-wave. The period set the time between each cycle of pulses. The
number of pulses sets how many pulses the B16-F10 cells will experience. The positive pulse
width determines how long the positive electrical field is exposed to the cells for each cycle of
pulse. The negative pulse width determines how long the negative electrical field is exposed to
the cells for each cycle. The polarity delay set the time distance between positive and negative
pulse width, which affects how the biphasic pulses interact with the B16-F10 cells. The
parameters used for the experimental group are as shown in Table 1. After electrotransfer for
each cuvette, cells were then pipetted into a 24-well plate containing 500ml of media in each
well. Plate were then incubated at 37 °C in 5% CO2 in a humidified atmosphere incubator for 48
hours.
Viability Assay
Viability was assessed through PrestoBlue Cell Viability Assay (Life Technologies
Corporatio1n, Eugene, Oregon) according to manufacturer’s instructions. After 24 hours of
incubation at 37 ℃ and 5% CO2 for the B16-F10 cells, media was prepared in volume of 12 mL.
Working PrestoBlue solution was made by mixing PrestoBlue with media at a 1:10 dilution of
reagent to media, and pipetted to thoroughly mixed the solution. Old cell media was removed
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from the plate and washed with 500 µL of PBS (Corning, Manassas, Virginia) per well. PBS
was removed and replaced with 500 µL of PrestoBlue working solution and incubated at 37 ℃
and 5% CO2 for 45 minutes. PrestoBlue solution was then transferred to a new sterile 24-well
plate to be read. Absorbance was read under a Spectra Max I3 (Molecular Device, San Jose,
California) at 570 nm with lid removed, and no shaking. Absorbance result were normalized to
the average of positive control group (group that received no pulse) and set to a viability
percentage by the equation:
Absorbance of each Well

Cell Viability (%) = Average Absorbance form Positive Control Wells x 100%

Microscopy
After cells in 24-well plate were incubated for 48 hours, cells were imaged at brightfield,
blue excitation B1E, and green excitation CY3 HYQ filter with using an inverted epifluorescence
microscope. Setting was set to 10x magnification and camera images were taken at 50 msec.
The brightfield setting is to view the cells by illuminating the sample with bright light. B-1E
operates with a 470-490 nm blue excitation light and will excite the sample to fluoresce green
light at an emission of 525 nm max. This setting is used to view cells expressing GFP. With the
blue light exciting the green fluorescent protein in the cells causing them to emit a green light
that can be view with the microscope. GFP from the Gwiz-GFP plasmid has an excitation peak
at 470-480 nm and an emission peak of 510 nm, which met the bandwidth of the filters used.
CY3 filter operates with a green light excitation of 512 to 550 nm and will excite the sample to
fluoresce red light at an emission of 570 to 615 nm. CY3 setting was used to view cells
expressing PI. With the green light exciting the PI chemical in the cell nucleus causing them to
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emit a red light. PI has an excitation peak at 535 nm and an emission peak of 617 nm max
therefore it falls into the CY3 emission and excitation band.
Transfection Efficiency
Once images were taken, cells were counted using ImageJ (National Institute of Health,
Bethesda, Maryland). Transfection Efficiency was based on cells counted in brightfield for
particular image and cell that fluorescence green color with the following equation:
Transfection Efficiency (%) =

# 𝑜𝑓 𝐺𝐹𝑃 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝐶𝑒𝑙𝑙𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑒𝑙𝑙𝑠

x 100%

Permeability Measurement
Once images were taken, cells were counted using ImageJ (National Institute of Health,
Bethesda, Maryland). Permeabilization was based on cells counted in brightfield for particular
image and cell that fluorescence red color with the following equation:
# 𝑜𝑓 𝑃𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝐶𝑒𝑙𝑙𝑠

Permeability (%) = 𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑒𝑙𝑙𝑠 x 100%

Statistical Analysis
All quantitative data were analyzed by performing a one-way ANOVA using Graphpad
Prism 8 (Graphpad Software, San Diego, California), with p-value <0.05 being statistically
significant. All quantitative data are presented with Standard Error of the Mean (SEM). Tukey
test was conducted on one-way ANOVA analysis to determine significant difference between
individual groups. One-way ANOVA is often used to determine the significant different across
an entire group with one independent variable such as changes in one parameter for each group.
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Group

Positive

Negative

Period

Number of

Positive

Negative

Polarity

Voltage

Voltage

(µs)

Pulses

Pulse

Pulse

Delay

(V)

(V)

Width

Width (µs)

(µs)

Agent added

(µs)

1

20

75

200

1579x1

75

20

2

GFP

2

20

75

200

1579x2

75

20

2

GFP

3

20

75

200

1579x8

75

20

2

GFP

4

40

75

190

1579x8

75

20

2

GFP

5

40

75

210

1579x8

85

20

2

GFP

6

40

75

240

1579x8

100

20

2

GFP

7

50

75

210

1579x8

85

20

2

GFP

8

90

75

210

1579x8

85

20

2

GFP

9

120

75

210

1579x8

85

20

2

GFP

10

120

75

100

1579x8

20

20

2

GFP

11

120

75

100

1579x8

20

20

2

PI

12

120

75

150

1579x8

50

20

2

GFP

13

120

75

150

1579x8

50

20

2

PI

14

120

75

190

1579x8

75

20

2

GFP

15

120

75

190

1579x8

75

20

2

PI

16

120

0

106

16

100

1

1

GFP

17

0

0

0

0

0

0

0

GFP

Table 1: Experimental Parameters of GET of B16-F10 cells. Group 1-3 were treated at
different number of pulses with GFP. Group 4-6 were treated with different positive pulse width
at low voltage with GFP. Group 7-9 were treated with different voltages with GFP. Group 10,
12, & 14 were treated with various pulse width at high voltage with GFP. Group 11, 13, & 15
were treated with various pulse width at high voltage with PI. Group 16 was treated with trains
of monophasic pulses with GFP. Group 17 was mixed with GFP but receive no pulse treatment.
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CHAPTER III

RESULTS

Pulse Number Effects on Transfection Efficiency
The first set of groups was used to investigate the effect of biphasic pulses with changes
in pulse number. The parameter with voltage of +20 V/-75 V, 200 us period, pulse width of +75
us/-20 us, 1579x8 pulses, and 2 us polarity delay, was used in another project within in the lab,
that transfected plasmid encoding GFP through GET into rat skin. The project was conducted in
vivo (unpublished data), thus the experiment for this study determined the effect of using less
pulses in-vitro. Group 1 was treated with 1579 pulses. Group 2 was treated with 1579x2 pulses.
Group 3 was treated with 1579x8 pulses. Based on the images shown in Fig 2A-C, it can be
inferred that viability is high, but transfection is low. As shown in Fig 2D, there is a significant
difference in transfection efficiency (p-value=0.0040). Tukey test shows that there is significant
difference between Group 1 and the DNA only group with p-value of 0.190 and significant
difference between Group 3 and DNA only group with p-value of 0.0033. Cell viability assay
was used to calculate viability of group 1, 2, & 3. From Fig 2E, the viability trends downward as
the number of pulses increases. One-way ANOVA showed a significant difference between all
groups for viability (p-value=0.0002). Tukey Test shows the viability significant difference is
between Group 1 and 3 with p-value of 0.0017. The viability significant difference is between
Group 2 and 3 with p-value at 0.0049. The significant difference is between Group 2 and DNA
only with p-value of 0.0437. Lastly the viability significant difference is between Group 3 and
DNA only with p-value of 0.0002.
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Figure 2: Increasing train of biphasic pulses has significant increase on transfection efficiency but reduces cell
viability. All groups were treated with voltage of +20 V/-75 V, period of 200 us, pulse width of +75 us/-20 us and
polarity delay of 2 us with GFP. A) Brightfield and fluorescence microscopy of Group 1. Group 1 was treated with
1579 pulses. B) Brightfield and fluorescence microscopy of Group 2. Group 2 was treated with 1579x2 pulses. C)
Brightfield and fluorescence microscopy of Group 3. Group 3 was treated with 1579x8 pulses. D) Transfection
efficiency was significantly difference between treatment. (One-way ANOVA p-value = 0.0.0040). E) Cell
viability between group shows significant difference. Cell viability does decrease with increase in pulse number.
(One-way ANOVA p-value =0.0002)
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Pulse Width Effects on Transfection Efficiency
Groups 4, 5, and 6 were used to investigate the effect with changes in biphasic pulse
width while at lower voltage. All groups mentioned were treated with voltage of +40 V/-75 V,
negative pulse width of 20 us, 1579x8 pulses, and 2 us polarity delay. Group 4 was treated with
+75 us pulse width and period of 190 us. Group 5 was treated with +85 us pulse width, and
period of 210 us. Group 6 was treated with +100 us pulse width, and period of 240 us. As
shown from the images in Fig 3A-C, cell viability is very high showing that increase in voltage
affect cell viability with the remaining parameters being the same as the GET of rat skin project
(unpublished data). Fig 3D shows significant difference in transfection efficiency with p-value
of 0.0499 from an ANOVA analysis. Significant difference was determined with the Tukey test
and it shows the significant difference is between Group 3 and DNA only with p-value of
0.0347. In Fig 3E, cell viability shows significant difference across the groups (p-value
=0.0002). Using the Tukey Test, the significant difference is between Group 1 and 2 with (pvalue = 0.0050), Group 1 and 3 with (p-value 0.0008), Group 2 and DNA (p-value = 0.0020),
and Group 3 and DNA only (p-value = 0.0004).
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Figure 3: Increasing positive pulse width has significant change on transfection efficiency but reduces cell
viability. All groups were treated with voltage of +40 V/-75 V, negative pulse width of 20 us, 1579x8 pulses and
polarity delay of 2 us with GFP. A) Brightfield and fluorescence microscopy of Group 4. Group 4 was treated with
+75 us pulse width and 190 us period. B) Brightfield and fluorescence microscopy of Group 5. Group 5 was treated
with +85 us pulse width and 210 us period. C) Brightfield and fluorescence microscopy of Group 6. Group 6 was
treated with +100 us pulse width and 240 us period. D) Transfection efficiency was significantly different between
groups. (One-way ANOVA p-value = 0.0499). E) Cell viability between group shows significant difference. Cell
viability decreases with increased positive pulse width. (One-way ANOVA p-value =0.0002)
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Applied Voltage Effects on Transfection Efficiency
Groups 7, 8, and 9 were used to observe the effect of raising positive voltages of biphasic
pulses. Each group were treated with negative voltage of -75 V, pulse width of +75 us/-20 us,
190 us period, and 2 us polarity delay. Group 7 was treated with +50 V amplitude. Group 8 was
treated with +90 V amplitude. Group 9 was treated with +120 V amplitude. Amplitude was
started off at +50 V vice +40 V since it was shown from previous experiment that it did not
significantly affect transfection efficiency. From images in Fig 4A-C, it can be assessed that cell
viability greatly diminish with increase voltages. In Fig 4C it is shown that the cell sample has
decrease to an extremely low amount. Fig 4D, shows transfection efficiency of the groups. As
presented, there are significant between the groups as transfection efficiency is significantly
improving with increases in voltages (p-value=0.0002). Tukey test show the significant
difference is between Group 7 and 9 (p-value = 0.0006), Group 8 and 9 with (p-value = 0.0093),
Group 8 and DNA only (p-value = 0.0197), and Group 9 and DNA only (0.0002). In Fig 4E, cell
viability is shown to be very significant (p-value <0.0001) with cell viability decreasing as
voltage increases. Tukey test shows that the both comparison between Group 7 and 8 (p-value =
0.0050), Group 7 and 9 (p-value<0.0001), Group 8 and 9 (p-value<0.0001), Group 7 and DNA
only (p-value = 0.0006), Group 8 and DNA only (p-value<0.0001), and Group 9 and DNA only
(p-value<0.0001).
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Figure 4: Increasing positive voltage increases transfection efficiency and reduces cell viability. All groups were
treated with negative voltage of -20 V, pulse width of +85 us/-20 us, 1579x8 pulses, period of 210 us and polarity
delay of 2 us with GFP. A) Brightfield and fluorescence microscopy of Group 7. Group 7 was treated with +50 V.
B) Brightfield and fluorescence microscopy of Group 8. Group 8 was treated with +90 V. C) Brightfield and
fluorescence microscopy of Group 9. Group 9 was treated with +120 V. D) Transfection efficiency significantly
increase with raises in positive voltage. (One-way ANOVA p-value<0.0001). E) Cell viability between group
shows significant difference. Cell viability decreases with increase in positive voltage, at 120 V cell viability is
significantly low. (One-way ANOVA p-value <0.0001).
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Pulse width Effects on Membrane Permeabilization
Group 11, 13, and 15 were used to determine if permeabilization does occur with
determined parameters. PI is the agent used to determine if pore formation occurs. All groups
were treated with voltage of +120 V/-75 V, negative pulse width of 20 us, 1579x8 pulses, and
polarity delay of 2 us. Group 11 was treated with positive pulse width of 20 us and period of 100
us. Group 13 was treated with positive pulse width of 50 us and period of 150 us. Group 15 was
treated with positive pulse width of 75 us and period of 190 us. The parameter was determined
from previous experiment that yielded no transfection efficiency or low cell viability. With the
previous experiments showing that high voltage yielded better transfection, but very low
viability, pulse width was chosen to be tested. With high voltage, lower pulses were considered
with respect to biphasic pulses. Images from Fig 5A-C shows that permeabilization does occur
throughout all groups. Data from Fig 5D shows that permeability does decrease with pulses
width, but the difference between the group is not significant (p-value=0.4519). Data from Fig
5E present significant difference among the groups for cell viability (p-value=0.0289). With the
Tukey test, the significant difference was between group 11 and group 15 with a p-value of
0.372.
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Figure 5: Increasing positive pulse width of biphasic pulses had no change on transfection efficiency but reduced
cell viability. All groups were treated with voltage of +120 V/-75 V, negative pulse width of 20 us, 1579x8 pulses,
and polarity delay of 2 us with PI. A) Brightfield and fluorescence microscopy of Group 10. Group 10 was treated
with +20 us and 100 us. B) Brightfield and fluorescence microscopy of Group 11. Group 11 was treated with +50
us and 150 us period. C) Brightfield and fluorescence microscopy of Group 12. Group 12 was treated with +75 us
and 190 us period. D) Permeability changes was not significant between all group with increasing positive pulse
width. (One-way ANOVA p-value = 0.4519). E) Cell viability between group shows significant difference. Cell
viability decreases with increase in positive pulse width. (One-way ANOVA p-value =0.0289).
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Pulse Width with Higher Applied Voltage
Groups 10, 12, and 14 were used to investigate if transfection efficiency is improved with
increasing pulse width at a high voltage. Each group had the same treatment as the previous
experiment except GFP was used instead of PI. The groups were all treated with +120 V/-75 V
voltage, negative pulse of 20 us, 1579x8 pulses, and polarity delay of 2 us. Group 10 was treated
with +20 us and 100 us period. Group 12 was treated with +50 us and 150 us period. Group 14
was treated with +75 us and 190 us period. Group 16 was treated with monophasic pulses at
+120 V/0 V voltage, 16 pulses, +100 us/-1 us pulse width, 106 us period, and polarity delay of 1
us. Group 16 served to be a positive control. Group 17 received no treatment and just had
plasmid encoding GFP added. From the images in Fig 6A-C, it can be visually inferred that
transfection has improved with lowering pulse width. Fig 6D shows images of Group 16 and
that the positive control did provide a baseline of suitable transfection. Fig 6E shows Group 17,
which is the negative control to provide that the cells with plasmid encoding GFP should not be
fluorescing unless it was properly delivered, for this case through pulse electric field. Fig 6F
shows how that increases in pulse width will significantly reduce GFP expression for the group
treated with biphasic pulses (p-value<0.0001). Using the Tukey Test, there are significant
difference between Group 10 and 14 (p-value<0.0001), Group 12 and 14 (p-value<0.0001),
Group 10 and Monophasic (p-value<0.0001), Group 10 and DNA only (p-value<0.0001), Group
12 and Monophasic (p-value = 0.0001), Group 12 and DNA only (<0.0001), Group 14 and
Monophasic (0.0041), Group 14 and DNA only (p-value = 0.0277), and Monophasic and DNA
only (p-value<0.0001). In Fig 6G, cell viability is shown to significantly decrease with increase
in pulse width (p-value<0.0001). Tukey Test shows significant difference between Group 10
and DNA only (p-value = 0.0003), Group 12 and DNA only (p-value<0.0001), Group 14 and
DNA only (p-value<0.0001), and Monophasic and DNA only (p-value<0.0001).
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Figure 6: Increasing positive pulse width of biphasic pulses decreases transfection efficiency and decrease cell
viability. All groups were treated with voltage of +120 V/-75 V, negative pulse width of 20 us, 1579x8 pulses, and
polarity delay of 2 us with GFP. A) Brightfield and fluorescence microscopy of Group 13. Group 13 was treated
with +20 us and 100 us. B) Brightfield and fluorescence microscopy of Group 14. Group 14 was treated with +50
us and 150 us period. C) Brightfield and fluorescence microscopy of Group 15. Group 15 was treated with +75 us
and 190 us period. D) Brightfield and fluorescence microscopy of Group 16. Group 16 is induced with
monophasic pulse with +120 V/0 V voltage, 16 pulses, pulse width of +100 us/-1 us, 106 us period, and 1 us polarity
delay. Group 16 served as a positive control for the study. E) Brightfield and fluorescent microscopy of Group 17.
Group 17 received no treatment and served as a negative control. F) Transfection efficiency changes significantly
changed between all group with treated with biphasic pulses. As positive pulse width increases, transfection
efficiency decrease (One-way ANOVA p-value < 0.0001). Comparison between the groups with monophasic pulses
shows significant difference between the three biphasic group and monophasic group (One-way ANOVA p-value
<0.0001) G) Cell viability between all group treated with biphasic pulses shows no significant with raises in
positive pulse width (One-way ANOVA p-value = 0.1438). Comparison between the three biphasic group with the
monophasic group shows no significant in viability with increasing pulse width (One-way ANOVA pvalue<0.0001).
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CHAPTER IV

DISCUSSION

The aim of this project is to determine if high transfection and high viability can be
achieved using biphasic pulses as compared to monophasic. For this experiment, high
transfection is considered high if transfection is higher than 30% transfection efficiency and cell
viability is higher than 80%. Each group utilizes three cuvettes and three wells to test
consistency of parameters. The experiment uses a monophasic pulse with parameters set with:
voltage at +120 V and -0 V, +100 us and -1 us pulse width, period at 1 second, 16 pulses, and 1
us polarity delay as a positive control. The setting of negative pulse width and polarity delay is
set to a value due to the B-10 Electrocell pulse generator requiring a minimum of 1 us for those
setpoint, but without any negative voltage amplitude set, those values are negligible. In other
studies, the biphasic pulses are typically conducted in burst meaning that a series of positive and
negative alternating pulse in short succession, followed by a short break to the next series based
on the settings. Due to the limitation of the B-10 Electrocell pulse generator, burst is not
feasible. Therefore, for this study, the pulse is generated with a +20 us wave, a 2 us delay, a -20
us wave, and then followed by a 58 us delay until the next pulse for a period of 100 us.
Fig 2 shows that transfection efficiency does significantly improve with increasing pulse
train and it does show that raising pulse train decrease the viability. The significant difference is
only at the x1 train and the x8 train when comparing each to the DNA only which shows no
transfection as expected. Therefore, transfection efficiency is enhanced compared to a naked
DNA injection, but transfection efficiency is still very low with x8 train only being at 2%. Fig 3
shows that transfection efficiency does significantly improved with raising pulse width, but
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viability does decrease with raising pulse width. Although the significant difference is only at
100us and DNA only. Since DNA only resulted in a transfection efficiency of 0, there is
significant difference with 100 us yielding 3%, but the transfection is still considered too low.
The pulses for groups shown in Fig 3 were decided based on data from the previous set of
groups. From those data, voltage needed to increase to raise permeability to potentially improve
transfection efficiency [19]. For this group the voltage was increase to 40 V, but the experiment
to determine the effect of changes with positive pulse width with an increase in voltage. The
results show very minimal increase in efficiency but a slight improvement from the previous
conditions.
Fig 4 show that transfection efficiency does significantly improve with increase in
voltage, but it shows that voltages do significantly decrease cell viability. This information
shows that voltage plays a crucial role in transfection and play a role in reducing cell viability.
The transfection efficiency increase is attributed to high power, but due to low population of
cells, the results can be represented a lot better with an improvement in sample size. Fig 5 shows
that the parameters being test induced permeabilization for all groups in that figure. The purpose
of using PI is to determine if permeabilization occurs with the condition tested. Fig 6 shows that
at high voltage, lowering pulse width does significantly improve transfection efficiency with
improvement in cell viability. The parameter of +120 V/-75 V voltage, +20 us/-20 us pulse
width, 100 us period, 1579x8 pulses, and 2 us polarity delay shows to yield the best result of
high transfection efficiency and high viability. The condition from the biphasic group in Fig 6
shared the same parameter as the group with the condition using PI. The significant difference
shown is between both the group that has pulse width of 20 us and 50 us as they both resulted in
high transfection efficiency at 43% and 42% respectively.
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In the study conducted by Tekle et al, they transfected NIH 3T3 fibroblast cells with
plasmid DNA SV2-neo, which makes mammalian cells resistance to the antibiotic G418 [22].
From their data, the parameter that had best transfection for biphasic pulses compared to
monophasic had cell viability of 62% for biphasic pulses. The fibroblast cells were exposed to
voltage amplitude at +5.5 kV and -5.5 kV, 400 us pulse duration, at 60 kHz frequency, and no
polarity delay, with electrode gap at 5 cm. Many studies have biphasic pulses parameter set to
100us pulse width and much lower voltage for tumor ablation [26][34][34][38]. The voltage
density is very high at +1.1 kV/cm and –1.1 kV/cm and high pulse during at 400 us. But in this
study, the parameter with high expression and viability has the voltage density at +1.2 kV/cm
and -.75 kV/cm and pulse duration is 1.26 seconds total. The reason for this difference in cell
viability is due to the lack of delay in Tekle’s parameter. For biphasic pulses, transmembrane
potential is not affected by the delay, but the nuclear envelope potential is. When the positive
wave decays, a lack of decay means that the nucleus is still charged as the negative wave
potential increase, thus potentially doubling the nuclear envelope potential in that one cycle [33].
Since there is still no delay between negative to positive wave, the nuclear envelope potential is
still affected. With the current research, the delay between polarity is set to 2 us, which gives
time for the nuclear envelope potential to zero out and the delay between the negative to positive
wave allows the nuclear envelope to zero out before the next cycle.
In the study by Vuyst et al, the author references Tekle’s result of having cell viability of
1-97% depending on the condition [20]. In Vuyst’s study, ECV304 human bladder carcinoma
cells were exposed to bipolar pulse of 50 kHz frequency, 2 ms pulse duration, and no delay
followed by 10 kHz frequency, 1 second pulse duration, and no delay with varying voltages to
transfect 6-CF fluorescent reporter dye [20]. Their best result with voltage density set to 1.2
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kV/cm has 98% viability but their transfection of 6-CF is at 20%. Vuyst’s study uses two
different frequencies and two different durations to transfect their cells and those repeated with
each pulse duration counted as a pulse for a total of 15 pulses [20]. The region of the short
pulses uses 100 bipolar pulses at +10 us and -10 us pulse width and the long pulses uses 10
bipolar pulses at +50 ms and -50 ms pulse width. The contributing factor for their transfection
efficiency is possibly due to the type of cells used, since B16-F10 murine melanoma cells have
different morphology and impedance as ECV304 human bladder carcinoma cells. Vuyst’s study
has lower pulse number and high voltage density. Mainly in Vuyst’s study they did not have a
delay in between polarity, which allows for bipolar pulse cancellation to occur. At delay less
than 50 us, biphasic pulses can cause bipolar pulse cancellation which will hinder uptake of
molecules [41]. In this study, polarity delay is only 2 us, which makes the experiment subjected
to bipolar cancellation as well. The power density between this study and Vuyst’s study are the
same, but the applied voltages are different. In this experiment the applied voltage is 120 V
while in Vuyst’s it is 60 V, which affects the cells closest to the electrodes. The electric field
strength is a very important variable for permeabilization for transfection [19].
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CHAPTER V
CONCLUSION
Biphasic pulses are typically used in tumor ablation due to the benefits of not causing
muscle contractions during treatment, alleviating the need for paralytic agent and anesthetic [34].
Recent research has explored the possibility of using biphasic pulses for gene electrotransfer.
Research conducted by Tekle et al has yielded high transfection efficiency with low cell viability
in NIH 3T3 Fibroblast cells of 62% [22] and research conducted by Vuyst et al has yielded high
cell viability of 98% and low transfection in ECV304 Human bladder carcinoma cells of only
20% [20]. The purpose of this study was to determine if high transfection and viability can be
achieved with biphasic pulses as compared to monophasic. Initially the transfection efficiency
was low with high viability both the pulse width and pulse train changes, but with extreme
changes from the voltage change experiment, transfection was high with very low viability. The
experiment with various pulse width at high voltage, shows that lower pulse width yielded high
transfection at 43% with viability at 84%. Those results meet the goal of this study in which
high transfection efficiency and viability was both achieved using biphasic pulses. In this
current study, biphasic pulses have shown improved transfection efficiency with high viability
for B16-F10 Murine melanoma cells. Further study of biphasic pulses can be conducted to
evaluate the possibility of gene electrotransfer without eliciting an action potential.
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CHAPTER VI
FUTURE WORK
From this study, setting the parameter to +120 V/-75 V amplitude, +20 us/-20 us pulse
width, 2 us polarity delay, 100 us period, and 1579x8 pulses showed enhanced transfection
efficiency of plasmid encoding GFP with high viability for B16-F10 cells using a B10 Bipolar
pulse generator. Future studies can test these parameters on skeletal muscle cells with GFP to
determine if high transfection and high cell viability will enhance with these parameters. In a
study by Andre et al, they conducted a study using high voltage pulses followed by low voltage
pulses for gene electrotransfer in B16-F10 cells, skeletal muscle cells, liver cells, and skin. The
conclusion they drew was that DNA can easily allocate in muscle and reaches a plateau of
luciferase expression at lower voltage (600 V/cm) than B16-F10 (800 V/cm) [23]. Muscle also
has high longevity and can serve to provide long-term secretion of proteins for systemic effect
[23].
Research involving biphasic pulses for irreversible electroporation finds therapeutic
results similar to monophasic pulse without muscle contraction. C2C12 Murine skeletal muscle
cells can be cultured in DMEM with 10% FBS until confluency at 40-50% confluency. At 90100% confluency, these cells will differentiate on their own. Differentiation can be determined
through immunohistochemistry. Immunohistochemistry for myosin can be done using anti-Fast
Myosin skeletal heavy chain antibody. Myosin is a protein that is found in muscle that is
responsible for muscle contraction. It is found in muscle cells once they are differentiated [44].
Transfection would be conducted in-vitro in a monolayer to observe transfection efficiency and
cell viability. Adjustment have to be made for parameters as transfection to muscle cells is
easier than tumor cells [23]. Once transfection efficiency and high viability is high, further
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studies can determine if muscle contraction can be avoided with high transfection and high
viability with C2C12 skeletal muscle progenitor cells seeded in a collagen sponge. Video
microscopy can be used to determine if notable contraction occurs in the collagen sponge. In
research it was determined that the polarity delay has a significant effect on the occurrence of
muscle contraction on a swine model [32]. The experiment had the same positive and negative
pulse width, positive and negative voltage, and pulse number. Raises in polarity voltage from 2
us to 5 us, or to 10 us yielded significant increase in muscle contraction [32]. The experiment
had voltage a lot higher due to conducting irreversible electroporation. Bipolar pulse
cancellation can be considered as the delay does affect bipolar pulse cancellation [41]. Bipolar
pulse cancellation is the phenomenon where the second wave which is reverse polarity follows
the first wave closely and lower the reduce the change in cell permeability. This is due to
occlusion molecules being pushed back into the pore from the second wave, lowering the change
in concentration inside the cell, restricting outside molecules from entering [41]. The study
concluded that <50 us is when bipolar pulse cancellation is to occur [41].
Once contraction of skeletal muscle is determined to be avoided, gene delivery of
plasmid in-vivo. The delivery can be done in a small animal model such as a rat. The rat model
should switch from plasmid encoding GFP to plasmid encoding luciferase. GFP detection in
vivo is difficult. Luciferase expression detection can be done on a live animal and can be done
over a period of several months, thus reducing the number of animals needed for these
experiments. Unlike fluorescence, luminescence is measured through a luminometer where the
light that is emitted by the gene that reacts with an enzyme that can be administer on site. The
luminometer contains photomultiplier tubes used to read the light signal and quantify using a
software program [45]. During the experiment an accelerometer can be implemented at the site
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of the pulsing to determine if any muscle contraction occurs. An accelerometer is used in
various studies of biphasic irreversible electroporation to determine muscle contraction [38].
Once the plasmid encoding luciferase is delivered to the rat model, 24 hours should be given for
the gene to express. After 24 hours, the rat model can be taken to IVIS luminometer where the
reactive enzyme is administered for the luciferase protein to activate. After approximately 5
minutes have elapsed, the luminescence reading can be used to determine if the treatment is
successful. The luminescence intensity will tell if the GET is a success. If the intensity is weak
or does not exist, the reactive enzyme does not trigger the protein in the cell.
Once in-vivo experiment in the rat model concludes high transfection and no contraction,
the experiment can be move into cardiomyocytes. Cardiomyocytes have limited cell renewal;
therefore, high cell viability is very crucial [46]. After a myocardial infarction, the ischemic
region of the heart is remodeled with fibroblast which deposits collagen in place of the
cardiomyocyte, that results in scar formation that does not contract [47]. When cardiomyocytes
are injured, they release an amount of cardiac troponin that can be found in the blood stream of a
person suffering myocardial infarction [45]. ELISA can be used to detect level of Troponin T in
the bloodstream. How ELISA works is it uses antigen and antibody interaction of the target
proteins. The antibody used to bind directly or indirectly (binds to another conjugate that binds
to the target) to the target will contain alkaline phosphatase or horseradish peroxidase where its
signal can be read. Troponin T is the cardiac regulatory protein that governs the calcium
facilitated interaction between the myosin and actin in the heart [48]. Like the previously
mentioned procedure, luciferase should be delivered to the heart through GET. For this protocol,
consideration should be made to the heartbeat of the rat model. When delivering the plasmid
encoding luciferase to the rat model’s heart, pulsing should be conducted while syncing to the R-
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Wave of the electrocardiography (ECG) [47]. Research on pulse electric field has been
conducted on or near the heart with respect to syncing to the R-wave of the ECG and has shown
little to no animal model morbidity [37][47]. Blood can be checked for troponin T using ELISA
to determine if cardiac injuries has occurred [47]. Luciferase will be measured like the skeletal
muscle protocol.
If transfection is high, and troponin T level is low [47], the experiment can move towards
pulsing during the T phase of the ECG to determine if an action potential occurs at the ventricle.
The T-phase is the portion of the cardiac cycle where the ventricle hyperpolarized or relax, in
which inducing an action potential at this phase can result in ventricular fibrillation [49]. If the
rat model shows no sign of muscle contraction of the heart, a larger animal model can be utilize
using bovines or porcine models.
Bovine and porcine models have hearts that can be comparable to humans. Using the
parameters from this study, plasmid encoding luciferase should initially be transfected during the
R-wave of the heart, while monitoring the ECG. If transfection is high, the cell viability is high,
and the level of troponin in the blood is low, pulse with the parameters from this study during the
T-phase of the ECG to determine if an action potential occurs. If large animal morbidity is low
and unrelated to the pulsing parameters, further research can be conducted using other genes. In
a study, gene transfer of phVEGF can be achieved using injection of naked DNA plasmid
encoding with Vascular endothelial growth factor (VEGF). Vascular endothelial growth factor is
a growth factor that promotes the formation of new blood vessels. The results were promising as
the perfusion score has improved [16]. The issue is that naked DNA is known for having low
efficiency and requires multiple application [4]. In another study, gene electrotransfer was used
to transfect pVEGF-A into an ischemic heart. VEGF-A is a growth factor that promote
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formation of new blood vessels, promotes stem cell mobilization and differentiation into
cardiomyocytes, promote cardiomyocyte proliferation, and promotes embryonic stem cell
differentiation in mouse [47]. The study induced trains of electrical pulses to the heart in sync
with the R-wave of an ECG while administering the VEGF-A to the ischemic area. The result
from that study shows that delivery of VEGF-A will reduce the size of the infract for an ischemic
heart that received the treatment and that pulsing the heart in sync with the R-wave will safely
deliver the gene [47]. Further research in this study can lead to gene delivery into skeletal
muscle and cardiac muscle without the concern for muscle contraction.
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